Amgen Inc (AMGN)
307.31
+7.01
(+2.33%)
USD |
NASDAQ |
May 08, 16:00
306.69
-0.62
(-0.20%)
After-Hours: 05:02
Amgen Market Cap: 164.85B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 08, 2024 | 164.85B |
May 07, 2024 | 161.09B |
May 06, 2024 | 160.65B |
May 03, 2024 | 166.99B |
May 02, 2024 | 149.34B |
May 01, 2024 | 148.79B |
April 30, 2024 | 146.95B |
April 29, 2024 | 148.26B |
April 26, 2024 | 144.81B |
April 25, 2024 | 144.49B |
April 24, 2024 | 146.44B |
April 23, 2024 | 146.72B |
April 22, 2024 | 145.85B |
April 19, 2024 | 144.25B |
April 18, 2024 | 140.93B |
April 17, 2024 | 141.64B |
April 16, 2024 | 142.48B |
April 15, 2024 | 142.41B |
April 12, 2024 | 143.36B |
April 11, 2024 | 144.82B |
April 10, 2024 | 142.92B |
April 09, 2024 | 145.01B |
April 08, 2024 | 144.39B |
April 05, 2024 | 144.79B |
April 04, 2024 | 143.80B |
Date | Value |
---|---|
April 03, 2024 | 147.19B |
April 02, 2024 | 148.15B |
April 01, 2024 | 151.82B |
March 28, 2024 | 152.37B |
March 27, 2024 | 153.43B |
March 26, 2024 | 151.01B |
March 25, 2024 | 150.50B |
March 22, 2024 | 148.00B |
March 21, 2024 | 148.42B |
March 20, 2024 | 146.33B |
March 19, 2024 | 145.63B |
March 18, 2024 | 145.18B |
March 15, 2024 | 144.09B |
March 14, 2024 | 145.52B |
March 13, 2024 | 147.91B |
March 12, 2024 | 148.20B |
March 11, 2024 | 147.57B |
March 08, 2024 | 146.71B |
March 07, 2024 | 146.23B |
March 06, 2024 | 148.23B |
March 05, 2024 | 148.26B |
March 04, 2024 | 149.73B |
March 01, 2024 | 150.23B |
February 29, 2024 | 146.75B |
February 28, 2024 | 148.70B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
101.68B
Minimum
May 31 2019
173.77B
Maximum
Feb 01 2024
133.11B
Average
132.97B
Median
Jan 28 2020
Market Cap Benchmarks
Gilead Sciences Inc | 80.95B |
Johnson & Johnson | 358.47B |
Eli Lilly and Co | 736.56B |
Merck & Co Inc | 328.13B |
Vertex Pharmaceuticals Inc | 108.08B |
Market Cap Related Metrics
PE Ratio | 43.90 |
PS Ratio | 5.591 |
Price to Book Value | 32.83 |
Price to Free Cash Flow | 23.26 |
Price | 307.31 |
Earnings Yield | 2.28% |
Operating PE Ratio | 23.70 |
Normalized PE Ratio | 43.90 |